SITU-SAFE is an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial (EudraCT 2019-000680-24) consisting of a single (SAD) and a multiple ascending dose (MAD) part of three dose cohorts each. In all individuals and doses, ILP100-Topical was safe and well-tolerated with no systemic exposure. A combined cohort analysis showed a significantly larger proportion of healed wounds (p = 0.020) on Day 32 by multi-dosing of ILP100-Topical when compared to saline/placebo (76% (73/96) and 59% (57/96) healed wounds, respectively). In addition, time to first registered healing was shortened by 6 days on average, and by 10 days at highest dose. ILP100-Topical increased the density of CXCL12+ cells in the wounds and local wound blood perfusion. The favourable safety profile and observed effects on wound healing support continued clinical development of ILP100-Topical for the treatment of complicated wounds in patients
Add to favorites:
Share:
Listing Description
Addressing target audiences and expressing needs
- To raise awareness and possibly influence policy
- Other blended financing
- Collaboration
The ILP100-Topical is being evaluated in phase 2 clinical trials in nonhealing wounds in diabetic patients (phase 2a) and surgical wounds in prediabetic, diabetic and obese patients (IND cleared for pivotal trial) and we are nor reaching out to investors and industrial parties to acclerate the development, also in specific reagions and other indications.
- Public or private funding institutions
- EU and Member State Policy-makers
- Research and Technology Organisations
R&D, Technology and Innovation aspects
Evaluation in two clinical trials in patients
pipeline in a product
geographical licencing possible
indication specific licencing possible
multiple stages of development have been published in patents and scientific journals
Pharmaceutical proucts need to become more cost efficient, the ILP-technology and on site production facilitates this
- Middle-East
- Asia
- Europe
- North America
- Global
Offer Details
Specifications and Deliverables:
Value Proposition:
Input Required from Customer:
Fields of Application:
Patent/Publication Number
Main Patent Claims:
Patent Family:
Video
Documents
No documents available.
Location and Map
Adress:
Contact the listings owner
Connect with the Listing Owner!
💬 Please log in now to send a direct message to the listing owner. Not a member yet? Sign up for free and start connecting today!
Related Funding and Finance Opportunities
Unlock Exclusive Funding Opportunities!
🔑 Get instant access to tailored funding opportunities that perfectly match your needs. This powerful feature is exclusively available to our professional members—helping you save time, stay ahead of the competition, and secure the right funding faster.
Upgrade to Professional now and never miss an important opportunity again! Already a member? Log in here to explore your matches.
Related Offers
Unlock Related Offers!
🚀 Gain access to related technology solutions that match your specific needs and interests—carefully selected to support your innovation goals. These offers are exclusively available to our professional members, helping you identify relevant technologies faster and start the right conversations with potential partners.
Upgrade to Professional now and never miss an important opportunity again! Already a member? Log in here to explore your matches.
Related Knowledgeable Resources
Viewers
See Who’s Interested in Your Offers!
🎯 Curious about who’s viewing your listings? Unlock insights into your last 20 visitors and discover potential leads instantly! This exclusive feature is only available to our professional members—helping you track engagement, connect with the right audience, and maximize your opportunities.
Upgrade to Professional now to gain access! Already a member? Log in here.